Investing In Ortho Pipeline Could Offset Pricing Pressures – Stryker, Zimmer
This article was originally published in The Gray Sheet
Executive Summary
Ortho-focused device firms Stryker and Zimmer hope plans to reinvest their cash into R&D and strategically planned acquisitions will help serve as a buffer against declining prices in the hip and knee replacement space.